(Q40459711)

English

Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies.

scientific article published on February 2005

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15705858

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705858%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 January 2020

title

Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15705858

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705858%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

1 reference

1 reference

1 reference

2

Napoleone Ferrara

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15705858

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705858%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 January 2020

author name string

Hans-Peter Gerber

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15705858

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705858%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 January 2020

language of work or name

English

0 references

publication date

1 February 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15705858

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705858%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

15705858

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705858%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 January 2020

volume

65

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15705858

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705858%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 January 2020

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15705858

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705858%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 January 2020

page(s)

671-680

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15705858

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705858%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 January 2020

Identifiers

PubMed publication ID

15705858

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15705858

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15705858%20AND%20SRC:MED&resulttype=core&format=json

(Q40459711)

Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)